Infratil Limited/Announcement
Infratil Limited logo

Completion of Acquisition of Pacific Radiology

M&A31 May 2021IFTUtilities

Infratil Limited 5 Market Lane, PO Box 320, Wellington, New Zealand Tel +64-4-473 3663 www.infratil.com



31 May 2021



COMPLETION OF ACQUISTION OF PACIFIC RADIOLOGY


On 29 April 2021 Infratil Limited (“Infratil”) announced that it had executed a conditional agreement to

acquire between 50.1% and 60% of Pacific Radiology Group Limited (“Pacific Radiology”) from

existing doctor shareholders.

Infratil confirms that its acquisition of Pacific Radiology was completed today for total cash equity

consideration of NZ$313.6 million. The consideration includes estimated transaction costs and is

subject to the usual post-completion adjustments for working capital and net debt.

Infratil expects that its ownership stake in Pacific Radiology will be between 54.1% and 56.2%, with

no change to equity consideration. Infratil’s final ownership will depend on the post-completion

adjustments and confirmation of doctor and management shareholdings.

Infratil’s Chief Executive Jason Boyes said “we are very pleased to complete the acquisition of Pacific

Radiology and we look forward to working with Pacific Radiology management and doctor

shareholders”.

On 19 May 2021, Infratil issued guidance for the year ended 31 March 2022 for Proportionate

EBITDAF of between $470 million and $520 million (excluding Tilt Renewables and Pacific

Radiology). Following completion of the Pacific Radiology acquisition, this has now been increased to

between $505 million to $555 million, which includes a 10-month contribution from Pacific Radiology.


Any enquiries should be directed to:


Mark Flesher, Investor Relations, Infratil Limited

mark.flesher@infratil.com

info@infratil.com

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.